Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today reported first quarter 2024 financial results and provided business updates.

The date and time of the Company's previously announced conference call remains unchanged, and will be held on Wednesday, May 8, 2024, at 8:30 a.m. ET. The event will be webcast live and can be accessed at ir.tripadvisor.com. A replay will be available on the website for three months.

THE WOODLANDS, Texas, May 8, 2024 /PRNewswire/ -- MIND Technology, Inc. ("MIND" or the "Company") (Nasdaq: MIND) (Nasdaq: MINDP) announced today that the previously announced virtual special meeting of holders of its 9% Series A Cumulative Preferred Stock (the "preferred stock") to approve an amendment to the Certificate of Designations, Preferences and Rights of the Preferred Stock has been rescheduled for June 13, 2024.  Additionally, the proposed amendment has been revised such that each share of preferred stock would be converted into 3.9 shares of common stock, $0.01 par value per share (the "common stock"), rather than the 2.7 shares ...

Today, Luminar (NASDAQ: LAZR), a leading global automotive technology company, provided its quarterly business update and financial results for the first quarter of 2024. These results and related commentary were published in a Shareholder Letter that was issued via an 8-K SEC filing and published on its Investor Relations website at https://investors.luminartech.com.